Última atualização: Agosto 17, 2026

Discurso de abertura do Diretor-Geral da OMS no briefing da Missão sobre a COVID-19 – 12 Marchar 2020

Второй пациент в Украине умер от коронавируса, заболели еще семь человек - Фото

12 Marchar 2020
Quase 125,000 casos já foram relatados à OMS, de 118 países e territórios. Nas últimas duas semanas, o número de casos relatados fora da China aumentou quase 13 vezes, and the number of affected countries has almost tripled.The second reason is that despite our frequent warnings, we are deeply concerned that some countries are not approaching this threat with the level of political commitment needed to control it.Let me be clear: describing this as a pandemic does not mean that countries should give up. The idea that countries should shift from containment to mitigation is wrong and dangerous.

On the contrary, we have to double down.

This is a controllable pandemic. Countries that decide to give up on fundamental public health measures may end up with a larger problem, and a heavier burden on the health system that requires more severe measures to control.

All countries must strike a fine balance between protecting health, preventing economic and social disruption, and respecting human rights.

We urge all countries to take a comprehensive approach tailored to their circumstances – with containment as the central pillar.

We are calling on countries to take a four-pronged strategy:

Primeiro, prepare and be ready.

There are still 77 countries and territories with no reported cases, e 55 countries and territories that have reported 10 cases or less.

And all countries with cases have unaffected areas. You have an opportunity to keep it that way. Prepare your people and your health facilities.

Segundo, detect, prevent and treat.

You can’t fight a virus if you don’t know where it is. That means robust surveillance to find, isolate, test and treat every case, to break the chains of transmission.

Terceiro, reduce and suppress.

To save lives we must reduce transmission. That means finding and isolating as many cases as possible, and quarantining their closest contacts. Even if you cannot stop transmission, you can slow it down and protect health facilities, old age homes and other vital areas – but only if you test all suspected cases.

And fourth, innovate and improve.

This is a new virus and a new situation. We’re all learning and we must all find new ways to prevent infections, save lives, and minimize impact. All countries have lessons to share.

WHO is working day and night to support all countries.

We have shipped supplies of personal protective equipment to 57 países, we’re preparing to ship to a further 28, and we’ve shipped lab supplies to 120 países.

We’ve published an R&D roadmap, with a set of core protocols for how studies should be done.

We’ve published a comprehensive package of technical guidance.

We’ve had more than 176,000 enrollments in our COVID training courses on OpenWHO.

We’re working with the World Economic Forum and the International Chambers of Commerce to engage the private sector. We’re also working with FIFA.

We’re working with our colleagues across the UN system to support countries to develop their preparedness and response plans, according to the 8 pillars.

And more than 440 million U.S. dollars has now been pledged to WHO’s Strategic Preparedness and Response Plan

We thank those countries that have contributed, especially those that have contributed fully flexible funds. Because this is a dynamic situation, we need the greatest flexibility possible to provide the best support possible. In the spirit of solidarity, we ask countries not to earmark funds for this response.

………….

WHO.int

Revisão de caso científico

Revisão de Caso Científico

Você gostaria de entender se os programas clínicos atuais, desenvolvimentos de pesquisa recentes, ou abordagens emergentes podem ser relevante para sua situação individual?

Compartilhe sua dúvida com nossa equipe de pesquisa científica e receba informações focadas nas áreas de pesquisa atual que podem ser relevante para o seu caso.

  • Revisão das informações que você fornece
  • Informações relevantes sobre pesquisas e programas clínicos
  • Uma resposta clara focada na sua situação
O que acontece a seguir? Envie sua pergunta, receber uma revisão científica focada, e obter uma resposta clara sobre pesquisas e programas clínicos relevantes para sua situação.
Sua revisão científica será preparada por Dr.. Helen Melnik, Doutorado , quem tem mais de 25 anos de experiência em pesquisa com células-tronco e programas clínicos internacionais.

Sem obrigação. Sua pergunta será analisada confidencialmente.

Apenas informações educacionais e de pesquisa. Este serviço não constituem aconselhamento médico, diagnóstico, prescrição, ou um personalizado recomendação de tratamento.


NBSciência

organização de pesquisa contratada

WhatsApp